About this trial
The purpose of this study is to determine or evaluate the risk factors such as smoking, family history etc. that cause esophageal cancer and to determine the genetic changes that lead to esophageal cancer. The investigators hypothesis is that systematic collection of data on the natural history of GERD and BE patients and risk factors for development of BE in patients with chronic GERD and progression of BE to dysplasia and adenocarcinoma will provide useful information to develop a decision model for risk stratification and risk reduction strategies in these patients.
As of March 17, 2011, 585 patients have consented at the Kansas City VA Medical Center.
Eligibility criteria
Qualifiers
Kansas City VA Patients with confirmed BE with and without dysplasia and patients with reflux disease (patients/cases); patients with other indicators for endoscopy such as anemia, weight loss, diarrhea, but without GERD and PE (controls).
Disqualifiers
Patients with uncontrolled significant comorbidities such as cardiovascular, pulmonary, renal, hepatic or metabolic diseases.
Presence of anticoagulation that would increase risk from biopsies
Patients unable to provide history
Patients with dyspepsia
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Midwest Biomedical Research Foundation
Lead sponsor
Kansas City Veteran Affairs Medical Center
Collaborator